Ps Lab Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 26.91%
- Profit Growth -29.05%
- Ebitda -108.24%
- Net Worth 101.85%
- Total Assets 211.10%
About Ps Lab Biosciences
Ps Lab Biosciences Private Limited (PLBPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 February 2017 (Seven years and 11 months 12 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prashant Madane, Shubhankar Karmakar, and Sigatapu Ram serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999PN2017PTC168965
- Company No.
168965
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Ps Lab Biosciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Madane  | Additional Director | 04-Oct-2019 | Current |
| Shubhankar Karmakar | Director | 17-Feb-2017 | Current |
| Sigatapu Ram | Director | 17-Feb-2017 | Current |
Financial Performance of Ps Lab Biosciences.
Ps Lab Biosciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 26.91% increase. The company also saw a substantial fall in profitability, with a 29.05% decrease in profit. The company's net worth Soared by an impressive increase of 101.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ps Lab Biosciences?
In 2019, Ps Lab Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Esperer Bio-Research Private LimitedShubhankar Karmakar is a mutual person
Muscleholic Academy Private LimitedPrashant Madane is a mutual person
- Rslk Dine And Delivery Private Limited
Shubhankar Karmakar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ps Lab Biosciences?
Unlock and access historical data on people associated with Ps Lab Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ps Lab Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ps Lab Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.